If rescheduled, cannabis would allow for tax break opportunities that cannabis businesses cannot currently access.

A bipartisan bill was recently introduced to the House to end the consideration of prior or current cannabis use when assigning security clearance for federal employment. 

Clearly California is a Cocannco target investment based in central California. The company has developed a proven, profitable model and has begun scaling. Founded in 2020, Clearly California has plans to expand and reach $5.5 million in sales by 2024.

23 states have legalized adult-use cannabis, 17 have legalized medical use, and only 10 prohibitive states remain.

In a newly published analysis by MJBiz, cannabis sales are projected to generate more than $100 billion in US economic impact in 2023. The impact is anticipated to increase by another 12.5% in 2024 and is projected to increase by 41% from 2023 to 2028. 

California has awarded nearly $20 million to 16 state universities to research many cannabis issues and compounds. These research matters include cannabis and mental health, delta-8, delta-10, and the first cannabis study on legacy genetics. 

After it failed to pass at the end of 2022, the Secure And Fair Enforcement (SAFE) Banking Act was reintroduced by bipartisan lawmakers in both chambers of Congress.

As we anticipate the revival of federal cannabis legalization as a vital issue in the 2024  presidential elections, the cannabis industry will continue to grow throughout legal states.

The FDA recently announced it is renewing its contract with Waterloo University to conduct a cannabis study. Since 2019, the FDA and the University have conducted International Cannabis Policy Study (ICPS).

The NBA is currently working on a groundbreaking agreement with its players that could allow players to also invest in and promote cannabis companies.